NM_000754.4:c.402G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000754.4(COMT):c.402G>A(p.Ala134Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,612,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.00041   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.00020   (  0   hom.  ) 
Consequence
 COMT
NM_000754.4 synonymous
NM_000754.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.406  
Publications
5 publications found 
Genes affected
 COMT  (HGNC:2228):  (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008] 
 MIR4761  (HGNC:41591):  (microRNA 4761) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 22-19963678-G-A is Benign according to our data. Variant chr22-19963678-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3239101.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.406 with no splicing effect.
BS2
High AC in GnomAd4 at 62 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COMT | NM_000754.4 | c.402G>A | p.Ala134Ala | synonymous_variant | Exon 4 of 6 | ENST00000361682.11 | NP_000745.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.000407  AC: 62AN: 152162Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
62
AN: 
152162
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000412  AC: 103AN: 249940 AF XY:  0.000413   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
103
AN: 
249940
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000199  AC: 290AN: 1460680Hom.:  0  Cov.: 30 AF XY:  0.000223  AC XY: 162AN XY: 726680 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
290
AN: 
1460680
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
162
AN XY: 
726680
show subpopulations 
African (AFR) 
 AF: 
AC: 
7
AN: 
33478
American (AMR) 
 AF: 
AC: 
40
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
100
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
11
AN: 
86254
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
52266
Middle Eastern (MID) 
 AF: 
AC: 
11
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
88
AN: 
1111984
Other (OTH) 
 AF: 
AC: 
32
AN: 
60382
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.474 
Heterozygous variant carriers
 0 
 20 
 41 
 61 
 82 
 102 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000407  AC: 62AN: 152280Hom.:  0  Cov.: 33 AF XY:  0.000524  AC XY: 39AN XY: 74462 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
62
AN: 
152280
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
39
AN XY: 
74462
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41550
American (AMR) 
 AF: 
AC: 
49
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
6
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
68010
Other (OTH) 
 AF: 
AC: 
2
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.508 
Heterozygous variant carriers
 0 
 4 
 8 
 11 
 15 
 19 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
COMT: BP4, BP7 -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.